Artisan Partners
REGN icon

Artisan Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Artisan Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,112,029
Closed -$418M – 283
2017
Q4 		$418M Sell
1,112,029
-370,829
-25% -$150M 0.79% 30
2017
Q3 		$663M Sell
1,482,858
-479,622
-24% -$228M 1.23% 21
2017
Q2 		$964M Buy
1,962,480
+29,252
+2% +$12.8M 1.81% 12
2017
Q1 		$749M Buy
1,933,228
+41,630
+2% +$15.4M 1.46% 13
2016
Q4 		$694M Buy
1,891,598
+118,896
+7% +$45.2M 1.44% 14
2016
Q3 		$713M Buy
1,772,702
+5,669
+0.3% +$2.27M 1.42% 12
2016
Q2 		$617M Sell
1,767,033
-27,599
-2% -$10.6M 1.31% 13
2016
Q1 		$647M Sell
1,794,632
-4,310
-0.2% -$1.78M 1.35% 15
2015
Q4 		$977M Sell
1,798,942
-282,555
-14% -$153M 1.92% 4
2015
Q3 		$968M Sell
2,081,497
-1,356
-0.1% -$728K 1.97% 4
2015
Q2 		$1.06B Buy
2,082,853
+17,170
+0.8% +$8.38M 1.96% 5
2015
Q1 		$933M Sell
2,065,683
-239,315
-10% -$101M 1.67% 6
2014
Q4 		$946M Sell
2,304,998
-553,763
-19% -$218M 1.64% 6
2014
Q3 		$1.03B Sell
2,858,761
-333,253
-10% -$112M 1.84% 5
2014
Q2 		$902M Sell
3,192,014
-43,396
-1% -$12.9M 1.56% 10
2014
Q1 		$972M Buy
3,235,410
+90,467
+3% +$27.9M 1.71% 7
2013
Q4 		$866M Buy
3,144,943
+8,340
+0.3% +$2.4M 1.55% 7
2013
Q3 		$981M Buy
3,136,603
+30,175
+1% +$7.94M 1.89% 4
2013
Q2 		$699M Buy
+3,106,428
New +$723M 1.5% 7

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners's REGN Position: Q1 2018 in Review

Artisan Partners sold out of Regeneron Pharmaceuticals (REGN) in Q1 2018, closing a stake of 1,112,029 shares — an estimated $418M sold.

Artisan Partners first reported a position in REGN in Q2 2013 and held it in 19 quarters. The position peaked at $1.06B in Q2 2015. 620 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • Artisan Partners reported no remaining Regeneron Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Artisan Partners sold 1,112,029 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $418M.
  • Artisan Partners first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Artisan Partners's Regeneron Pharmaceuticals position peaked at $1.06B in Q2 2015.
  • 620 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Artisan Partners's 13F filing for Q1 2018, filed 10 May 2018.